The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Fri, 23rd Jan 2015 13:36

Director Dealings Summary - Week Ended January 23        
Company Name Position Buy or Sell Number of Shares Resulting Holding *Note
1PM Ron Russell Non-Executive Director Buy 40,907 7.3 million After posting positive results
Aberdeen Asset Management Richard Mully Non-Executive Director Buy 15,000 30,000  
Amati VCT Paul Jourdan Manager Buy 34,698 282,506  
Bankers Investment Trust David Wild Non-Executive Director Buy 8,403 12,803  
BlueRock Diamonds John Kilham CTO Buy 100,000 250,000  
British Land Co Charles Maudsley Director Sold 50,000 Undisclosed  
Cloudbuy Lyn Duncan CEO Buy 20,000 21.1 million 2 weeks after signing new website deal
Enteq Upstream David Steel CFO Buy 12,659 81,240 3 days after profit warning
e-Therapeutics Steve Medlicott  CFO Buy 150,000 250,000  
Flowgroup Nigel Canham CFO Buy 68,400 68,400 First purchase
Fulcrum Utility Services Stephen Gutteridge Non-Executive Director Buy 125,000 529,166 Week after deciding to take its operational delivery in-house
Games Workshop Elaine O'Donnell Non-Executive Director Buy 1,500 1,500 First purchase
Hilton Food Robert Watson CEO Sold 90,000 2.9 million 11 days after posting positive results
Judges Scientific Alex Hambro Chairman Sold 15,000 77,500 Same day as company bought Armfield Ltd for GBP8.3 million
Kingfisher Véronique Laury CEO Buy 100,000 Undisclosed  
Mithril Capital Rodger Sargent Non-Executive Director Buy 675,000 5.4 million  
Lamprell John Macdonald Senior Manager Buy 19,185 51,185 1 week after profit warning
Leed Resources Charles Zorab Non-Executive Director Buy 3.3 million 3.3 million 2 weeks after company agreed to invest in limestone miner
Lekoil Gregory Eckersley Non-Executive Director Buy 45,000 2.8 million Same day as project in Nigeria declared "robust"
London Capital Group Charles-Henri Sabet Chairman Buy 250,000 1.7 million Day after loan note conversions announced
Proton Power Thomas Melczer Business Development Director Sold 250,000 250,000 2 days after reporting a loss
REA Holdings Irene Chia Non-Executive Director Buy 1,000 Undisclosed  
Renew Holdings Brian May CEO Sold 350,000 494,193 Sold from his wife's shareholding
Rosslyn Data Tech Hugh Cox Director Buy 38,838 9.5 million  Same day as company posted a loss
Shanta Gold Luke Leslie Non-Executive Director Sold 3.3 million nil Sold  entire stake day after positive Q4 update
             
*Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event.
When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director
             
Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam    
             
Copyright 2015 Alliance News Limited. All Rights Reserved.        

More News
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
21 May 2015 08:23

e-Therapeutics Says First Patient Enrolled In Phase Ib ETS2101 Trial

Read more
31 Mar 2015 08:21

e-Therapeutics Loss Widens As It Increases Development Spending

Read more
26 Feb 2015 14:12

e-Therapeutics Believes Drug Discovery Process Producing Higher Yield

Read more
21 Jan 2015 11:42

DIRECTOR DEALINGS: e-Therapeutics Finance Director Buys 150,000 Shares

Read more
16 Oct 2014 07:40

E-Therapeutics Appoints Sean Nicholson As Executive Director

Read more
16 Sep 2014 09:08

e-Therapeutics Loss Widens On Pipeline Development; Chair To Retire

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
4 Jul 2014 16:30

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or

Read more
4 Jul 2014 08:59

DIRECTOR DEALINGS: e-Therapeutics Finance Chief Buys 100,000 Shares

Read more
25 Jun 2014 16:02

DIRECTOR DEALINGS: e-Therapeutics Non-Executives Allotted New Shares

Read more
12 May 2014 11:49

e-Therapeutics Loss Widens As It Continues Pipeline Development

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e

Read more
8 May 2014 13:30

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians

Read more
8 May 2014 12:23

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.